Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Diaverum acquires two clinics in Brazil, and enters the largest country in Latin America

Diaverum creates a strong presence from the start through the acquisition of the two clinics in Ameng and Clinese. 900 patients will be treated in the clinics and the number is expected to grow.SAO PAULO/GOTHENBURG, (January 31st, 2018) - Diaverum, one of the leading renal care providers worldwide, announce the acquisition of two dialysis treatment centres in the States of Sao Paulo and Sergipe, respectively. With these two acquisitions Diaverum will treat 900 dialysis patients on the Brazilian market and aims to expand further during 2018. Both Ameneg and Clinese have impressive numbers

Dome Energy AB gives reserve update; Proven reserves value up 130%

Dome Energy AB.  (herein after “Dome” and/or “the Company”) announces a large increase in its Oil and Gas reserves. A third-party engineering company has in a report valued Domes proven reserves at $124mm, which is up from $53mm at the end of 2016, with an addition of high quality probable reserves valued at $16mm. The reserve volumes have increased with 70% during the same period, from 4.5 MBOE to 7.6 MBOE. Paul Mørch, CEO: “We are pleased to see that we have been able to achieve this large increase in reserves and value. A large portion of this value is

NextCell Pharma changes ticker to NXTCL

NextCell Pharma AB ("NextCell") announces that it will change its ticker on Aktietorget to NXTCL.Since its listing on Aktietorget (2017-07-13), NextCell has been traded using the ticker NEXTCL. Management hasdecided to change the ticker to NXTCL. The new abbreviation might also be used in general market communicationsand company branding. The new ticker will become effective as per 2018-02-07, the company name and ISIN-code (SE0009723125) willremain the same. This information is the information that NextCell Pharma AB is required to disclose under the EU Market AbuseRegulation.

Financial Statements Release 2017: Excellent finish to the record-strong year 2017

UPM-Kymmene Corporation      Financial Statements Release         31 January 2018 at 09:45 EET Financial Statements Release 2017:Excellent finish to the record-strong year 2017 Q4 2017 highlights · Comparable EBIT increased by 29% to EUR 366 million (283 million in Q4 2016). · Sales prices and delivery growth boosted earnings, outstripping the impact of higher input costs and unfavourable currencies. · Strong operating cash flow at EUR 407 million (405 million). · Net debt decreased to EUR 174 million (1,131 million). · UPM and the Government of Uruguay

The rights issue of Oncology Venture is oversubscribed

Hørsholm, Denmark, January 31st, 2018 – Oncology Venture Sweden AB (”Oncology Venture”) today announces that the company’s rights issue of approximately SEK 44.7 million in order to finance planned clinical trials with existing drug candidates and establish a financial buffer, has been oversubscribed. The rights issue was subscribed to approximately SEK 59.6 million, responding to a subscription rate of approximately 133 percent. Through the rights issue a total of 2.745.143 shares are issued and Oncology Venture are provided approximately SEK 44.7 million before issuing costs. The issuing

Eyeonid Group AB secures external financing of up to SEK 100 million and issues free warrants to its shareholders

Eyeonid Group AB ("Eyeonid Group") has signed an agreement relating to an investment of up to SEK 100 million. The capital will be used for expanding our sales & marketing activities in line with the strategy of reaching out to a global market with Eyeonid Group’s products.The transaction is carried out through a private placement of convertible notes with warrants attached in several tranches spread over 36 months (each, a “Tranche”). Eyeonid Group will receive SEK 20 million through the first Tranche. Existing shareholders will receive free warrants to protect them against dilution.- "

Beijer Ref Q4 2017

Strongest-ever fourth quarterNet sales for the fourth quarter of 2017 increased by 9 per cent compared with the corresponding period in the previous year and amounted to SEK 2,401M (2 199). Operating profit for the fourth quarter of 2017 amounted to SEK 179M (145). It is an improvement of 24 per cent compared with the same period last year. Profit for the quarter amounted to SEK 146M (100). Profit per share amounted to SEK 3.39 (2.29). The acquisition of Tecsa (Pty) Ltd has now been approved by the competition authority in South Africa and the planned takeover date is expected

C-RAD AB – Consolidated Year-End report January-December 2017

POSITIVE RESULT FOR THE FOURTH QUARTER 2017 Key events in the period October - December 2017 FOURTH QUARTER 2017                                                    · Order intake: 47.5 (41.9) MSEK, +13%. · Revenues: 42.0 (27.3) MSEK, +54%. · Operating profit: 1.1 (-4.4) MSEK. · Net results after tax: 0.8 (-4.6) · Result per share: 0.03 (-0.16) SEK. Comments from Tim Thurn, CEO: We delivered another solid quarter and a strong finish to the year with significant growth in revenue, an operating profit and a significant increase in order intake compared to the same

Experienced finance professional becomes new CFO of Soluno

Jane Carlgren took over as CFO of Soluno BC on 1 January 2018. She has more than 20 years of experience in the fields of economics and finance from her previous roles in large and medium-sized companies. “Given her strong background and expertise, Jane will be a great asset to Soluno, both strategically and in day-to-day operations,” says Mattias Ohde, CEO of Soluno BC.Jane Carlgren began her career in the finance industry with Kinnevik during its tough years in the 90s. She later moved to Åhléns and then to Telefos, where she gained equivalent experience in two other industries. In order

Afound – an innovative off-price marketplace – launches in 2018

Afound will be a marketplace, a “style- and deal-hunting paradise” selling discounted fashion and lifestyle products, with both external and the H&M group’s own brands, offering a wide range of well-known, popular brands for both women and men. Afound will present a carefully selected, season-less range from Swedish and international brands in a variety of price segments both online and in physical stores. Afound will also launch unique, limited product releases from a range of brands, all at attractive prices. “We see big potential for Afound and are looking forward to introducing the

President and CEO Jonas Samuelson’s comments on the results for the fourth quarter 2017

Operating margin target achieved for 2017Electrolux reached an operating margin of 6.1% during 2017, an improvement of close to 20%. This was an important step on the journey towards profitable growth, supported by a strong focus on product portfolio management and cost efficiencies. The year ended with a strong fourth quarter delivering an organic growth of 4% and a margin of 6.1%. In 2017, we had a consistent focus on driving sustainable profitability through portfolio management and cost efficiencies. As a result, we improved earnings across all our business areas and generated a

New number of votes in Bonava AB due to conversion

The number of shares and votes in Bonava AB has changed due to conversions of a total of 10,525 shares of series A to a total of 10,525 shares of series B.According to Bonava’s articles of association, owner of a share of series A has the right to request that such share is converted to a share of series B. In December, 10,525 shares of series A shares were converted to 10,525 shares of series B at the request of shareholders. Following the conversions, there were, as of January 31, the last trading day of the month, a total of 108,435,822 registered shares in Bonava AB. Of these 13,158,980

Invitation to presentation of Bactiguard’s year end report for 2017 on February 6, 2018

Bactiguard Holding AB (publ) publishes the year end report for 2017 on Tuesday, February 6, 2018 at 8:00 CET.In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on February 6. CEO Christian Kinch and CFO Cecilia Edström will present the interim report and answer questions. The year end report and a presentation for the conference call will be available at Bactiguard’s website www.bactiguard.com from 8:00 CET the same day.     To participate in the conference call, please dial +46 8 566 426 99 For further information, please contact:

Electrolux Consolidated Results 2017

Highlights of the fourth quarter of 2017· Net sales increased to SEK 32,366m (32,144). · Organic sales growth was 4.0%, contribution from acquisitions and divestments was 1.4% while currency translation had a negative impact of 4.7%.  · Operating income increased to SEK 1,969m (1,616), corresponding to a margin of 6.1% (5.0). · Four business areas achieved an operating margin of more than 8%. · Operating cash flow after investments amounted to SEK 2.1bn (2.6). · Income for the period increased to SEK 1,930m (1,272), and earnings per share was SEK 6.72 (4.43). · The

ENQUEST PLC ANNOUNCES AGREEMENT WITH BP ON THISTLE DECOMMISSIONING

31 January 2018  Following the completion of the acquisition of an initial 25% interest in the Magnus oil field on 1 December 2017, EnQuest PLC ('EnQuest') is pleased to announce it has agreed with BP to undertake the management of the physical decommissioning activities for Thistle and Deveron. Under the terms of this agreement with BP: · EnQuest will receive $30 million in cash in exchange for undertaking the management of the physical decommissioning and making payments by reference to 3.7% of the gross decommissioning costs of the Thistle and Deveron fields when spend

Proposal of the Shareholders' Nomination Board on the composition and remuneration of the Board of Directors of Finnair Plc

The Shareholders' Nomination Board proposes to Finnair Plc's Annual General Meeting (AGM) to be held on 20 March 2018 that the number of members of the Board of Directors would be confirmed as eight. Proposal on the composition of the Board of Directors The Shareholders' Nomination Board proposes that Colm Barrington, Mengmeng Du, Maija-Liisa Friman, Jouko Karvinen, Jonas Mårtensson and Jaana Tuominen be re-elected as members of the Board of Directors, and that Montie Brewer and Henrik Kjellberg be elected as new members to the Board of Directors. All candidates have given their

Increase of number of votes in Hansa Medical AB (publ)

The number of votes in Hansa Medical AB (publ) has changed as a result of conversion of in total 70,739 C shares into ordinary shares carried out in January under Hansa Medical’s long-term incentive programme.As of January 31, 2018, the total number of registered and outstanding shares of Hansa Medical amounts to 38,208,386 of which 37,878,125 ordinary shares, together carrying 37,878,125 votes, and 330,261 C shares, together carrying 33,026.1 votes. The total number of votes in Hansa Medical is 37,911,151.1.   This information is information that Hansa Medical AB (publ) is obliged to

Pihlajalinna acquires Kymijoen Työterveys

Pihlajalinna Plc     Press release       31 January 2018 at 9:00 a.m. Pihlajalinna acquires Kymijoen Työterveys Pihlajalinna acquires the entire share capital of Kymijoen Työterveys Oy from the City of Kotka. The transaction was completed on 30 January 2018. The four clinics of Kymijoen Työterveys became part of Pihlajalinna’s chain of private clinics. With the acquisition of Kymijoen Työterveys, Pihlajalinna expands its operations in the Kymenlaakso, Kotka and Kouvola areas, and realises its national expansion plan before the implementation of the healthcare and social welfare

RNB issues senior secured notes of SEK 400 M

RNB Retail and Brands AB (publ) (the “Company”) issues senior secured notes of SEK 400 M with a maturity of 3 years on the Nordic bond market.The notes have a floating interest rate of Stibor 3m + 600 basis points with a final maturity date on 2 February 2021. Notes may be issued up to a total maximum amount of SEK 600 M. The initial notes issue amounts to SEK 400 M. The Company intends to apply for listing of the notes on Nasdaq Stockholm. The proceeds from the contemplated notes issue will be used for refinancing of outstanding financial indebtedness and general corporate purposes. “

Notice of extraordinary general meeting in Xspray Pharma AB (publ)

The shareholders of Xspray Pharma AB (publ) are hereby summoned to attend the extraordinary general meeting (“EGM”) on Tuesday, 20 February, 2018, at 11.00 CET at Advokatfirman Vinge’s offices on Smålandsgatan 20 in Stockholm, Sweden.Right to participate Those who have been recorded as shareholders in the share register kept by Euroclear Sweden AB as per Wednesday 14 February, 2018, and who, no later than on Wednesday 14 February, 2018, have given notice to the company of their intent to participate at the EGM, shall have the right to participate at the EGM. Notice to participate shall

Year-end Report 2017

GOOD GROWTH AND IMPROVED GROSS PROFIT FOURTH QUARTER(¹) · Net sales increased by 9 percent to SEK 1,199.8 (1,100.3) million · Gross profit increased by 14 percent to SEK 261.7 (230.5) million · Operating income before depreciation and amortization was SEK 52.4 (62.9) million · Operating income totaled SEK 35.6 (42.7) million · Basic and diluted earnings per share including discontinued operations amounted to SEK 0.05 (0.13) · Cash and cash equivalents increased to SEK 624.7 (435.2) million at year-end · The envisioned group structure attained with the divestment of

Swedbank receives number one Prospera ranking for Trade Finance

Swedbank has received a number one ranking for Trade Finance in the 2018 survey from Prospera. In one year, Swedbank´s ranking has risen from fifth place to first.Prospera, part of Kantar Sifo, is a well-known benchmark in the financial and legal industry. To determine the ranking, Prospera surveyed the Trade Finance Directors, CFOs, Risk Managers and Treasurers of 94 major organisations within Sweden according to criteria focusing on sales function, risk, risk advisory and Trade Finance specialist/support capabilities, as well as general criteria such as competitive fees, turnaround time

Wärtsilä's Board of Directors decides on a new share-based incentive scheme

Wärtsilä Corporation, Stock exchange release, 31 January 2018 at 9.00 am EETWärtsilä's Board of Directors decides on a new share-based incentive scheme Wärtsilä’s bonus scheme 2018 comprises 1,717,000 bonus rights. The bonus payment is based on the share price development during the three-year period on the basis of a share price of EUR 67.74. The bonus cannot exceed EUR 25.40 per bonus right and it takes into account 100% of dividends paid. The 2018 bonus scheme will be due for payment in February 2021. The bonus scheme applies to Wärtsilä’s senior management, consisting of

H & M Hennes & Mauritz AB Full-year report

Full-year (1 December 2016 – 30 November 2017) · The H&M group continued to grow globally in 2017. Sales including VAT increased by 4 percent to SEK 231,771 m (222,865) in the financial year. Sales increased by 3 percent in local currencies. Sales excluding VAT amounted to SEK 200,004 m (192,267). · Gross profit increased to SEK 108,090 m (106,177). This corresponds to a gross margin of 54.0 percent (55.2). · Profit after financial items amounted to SEK 20,809 m (24,039). The group’s profit after tax amounted to SEK 16,184 m (18,636), corresponding to SEK 9.78 (11.26) per share.

There are no items matching the current filter
There are no more items matching the current filter
Back to top